Jyoti Ahlawat

Dr. Jyoti Ahlawat

Chemistry and Biochemistry Department, The University of Texas at El Paso, El Paso, TX, USA
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2018 in Molecules
Verified
Journal Article
Open access
PDF file
Jyoti AhlawatJyoti Ahlawat
Jyoti Ahlawat
GHGabriela Henriquez
Gabriela Henriquez
Mahesh NarayanMahesh Narayan
Mahesh Narayan
While pharmaceutical drugs have revolutionized human life, there are several features that limit their full potential. This review draws attention to some of the obstacles currently facing the use of chemotherapeutic drugs including low solubility, poor bioavailability and high drug dose. Overcoming these issues will further enhance the applicability and potential of current drugs. An emerging technology that is geared towards improving overall therapeutic efficiency resides in drug delivery systems including the use of polymeric nanoparticles which have found widespread use in cancer therapeutics. These polymeric nanoparticles can provide targeted drug delivery, increase the circulation time in the body, reduce the therapeutic indices with minimal side-effects, and accumulate in cells without activating the mononuclear phagocyte system (MPS). Given the inroads made in the field of nanodelivery systems for pharmaceutical applications, it is of interest to review and emphasize the importance of Polymeric nanocarrier system for drug delivery in chemotherapy.

15 July 2020 in Applied Sciences
Verified
Journal Article
Open access
PDF file
SAShima Masoudi Asil
Shima Masoudi Asil
Jyoti AhlawatJyoti Ahlawat
Jyoti Ahlawat
GGGileydis Guillama
Gileydis Guillama
Mahesh NarayanMahesh Narayan
Mahesh Narayan
In addition to adverse health outcomes, neurological disorders have serious societal and economic impacts on patients, their family and society as a whole. There is no definite treatment for these disorders, and current available drugs only slow down the progression of the disease. In recent years, application of stem cells has been widely advanced due to their potential of self-renewal and differentiation to different cell types which make them suitable candidates for cell therapy. In particular, this approach offers great opportunities for the treatment of neurodegenerative disorders. However, some major issues related to stem-cell therapy, including their tumorigenicity, viability, safety, metastases, uncontrolled differentiation and possible immune response have limited their application in clinical scales. To address these challenges, a combination of stem-cell therapy with nanotechnology can be a solution. Nanotechnology has the potential of improvement of stem-cell therapy by providing ideal substrates for large scale proliferation of stem cells. Application of nanomaterial in stem-cell culture will be also beneficial to modulation of stem-cell differentiation using nanomedicines. Nanodelivery of functional compounds can enhance the efficiency of neuron therapy by stem cells and development of nanobased techniques for real-time, accurate and long-lasting imaging of stem-cell cycle processes. However, these novel techniques need to be investigated to optimize their efficiency in treatment of neurologic diseases.

11 April 2019 in Materials
Verified
Journal Article
Open access
PDF file
Jyoti AhlawatJyoti Ahlawat
Jyoti Ahlawat
Eva M DeemerEva M Deemer
Eva M Deemer
Mahesh NarayanMahesh Narayan
Mahesh Narayan
The aim of the present investigation was to study the anti-oxidant effect of chitosan nanoparticles on a human SH-SY5Y neuroblastoma cell line using a rotenone model to generate reactive oxygen species. Chitosan nanoparticles were synthesized using an ionotropic gelation method. The obtained nanoparticles were characterized using various analytical techniques such as Dynamic Light Scattering, Scanning Electron Microscopy, Transmission Electron Microscopy, Fourier Transmission Infrared spectroscopy and Atomic Force Microscopy. Incubation of SH-SY5Y cells with 50 µM rotenone resulted in 35–50% cell death within 24 h of incubation time. Annexin V/Propidium iodide dual staining verified that the majority of neuronal cell death occurred via the apoptotic pathway. The incubation of cells with chitosan nanoparticles reduced rotenone-initiated cytotoxicity and apoptotic cell death. Given that rotenone insult to cells causes oxidative stress, our results suggest that Chitosan nanoparticles have antioxidant and anti-apoptotic properties. Chitosan can not only serve as a novel therapeutic drug in the near future but also as a carrier for combo-therapy.

16 January 2024 in Journal of Nanotheranostics
Verified
Journal Article
Open access
PDF file
DWDaisy Wilson
Daisy Wilson
Jyoti AhlawatJyoti Ahlawat
Jyoti Ahlawat
Mahesh NarayanMahesh Narayan
Mahesh Narayan
The use of carbon nanomaterials including fullerenes, carbon nanotubes, carbon nano-onions, carbon dots and carbon quantum dots for environmental applications has increased substantially. These nanoparticles are now used in the development of sensors and switches, in agriculture as smart fertilizers and in the biomedical realm for cancer therapy intervention, as antioxidants, in gene delivery and as theranostics. Here, we review the role of fullerenes as neuroprotectants. Their sp2 hybridized architectures and ability to intervene in the soluble-to-toxic transformation of amyloidogenic trajectories is highlighted here, along with other physico–chemical properties that impact interventional efficacy. Also highlighted are drawbacks that need to be overcome and future prospects.

27 February 2024 in Exploration of Neuroprotective Therapy
Verified
Journal Article
Open access
PDF file
DWDaisy L. Wilson
Daisy L. Wilson
Jyoti AhlawatJyoti Ahlawat
Jyoti Ahlawat
Mahesh NarayanMahesh Narayan
Mahesh Narayan
Carbon nanotubes, an emerging class of carbon nanomaterials, possess tremendous potential for application in biotechnology and biomedicine particularly in neurological disorders. Carbon nanotubes owing to their fascinating properties have the potential to revolutionize medicine and technology, particularly in the realm of drug delivery, biosensing, bioimaging, and as therapeutic agents to tackle complex neurological disorders such as Alzheimer’s and Parkinson’s disease. In this review, a summary of the use of carbon nanotubes for neuropathological outcomes such as alleviating oxidative stress and amyloid formation, which are well-studied molecular outcomes associated with Alzheimer’s and Parkinson’s disease. In the end, challenges associated with the clinical testing of carbon nanotubes and possible ways to overcome them are highlighted.

27 May 2024 in Cell Biochemistry and Biophysics
Verified
Journal Article
Closed access
PDF file
DWDaisy L. Wilson
Daisy L. Wilson
ACAna Carreon
Ana Carreon
SCSampath Chinnam
Sampath Chinnam
HSHamidreza Sharifan
Hamidreza Sharifan
Jyoti AhlawatJyoti Ahlawat
Jyoti Ahlawat
Mahesh NarayanMahesh Narayan
Mahesh Narayan